Bank of New York Mellon Corp Invests $78.77 Million in Revvity Inc. $RVTY

Key Points

• Bank of New York Mellon purchased 707,941 Revvity shares worth approximately $78.8 million, giving it a 0.63% stake. Institutional investors collectively own 86.65% of the company.
• Revvity beat quarterly expectations with adjusted EPS of $1.41 versus the $1.21 consensus and revenue of $729.69 million, though revenue declined 1.3% year over year. The company reaffirmed fiscal 2026 EPS guidance of $5.30–$5.40.
• Shares recently traded near a 52-week high at $124.79, while analysts maintain a consensus “Hold” rating with an average price target of $108.36. Revvity also declared a quarterly dividend of $0.07 per share.

Bank of New York Mellon Corp purchased a new stake in Revvity Inc. (NYSE:RVTY - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 707,941 shares of the company's stock, valued at approximately $78,766,000. Bank of New York Mellon Corp owned 0.63% of Revvity as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. Ascentis Independent Advisors purchased a new position in shares of Revvity in the first quarter worth approximately $29,000. CYBER HORNET ETFs LLC purchased a new position in Revvity during the 2nd quarter worth approximately $32,000. MUFG Securities EMEA plc purchased a new position in Revvity during the 2nd quarter worth approximately $34,000. SJS Investment Consulting Inc. raised its stake in Revvity by 5,210.0% during the 1st quarter. SJS Investment Consulting Inc. now owns 531 shares of the company's stock valued at $47,000 after purchasing an additional 521 shares during the period. Finally, Headlands Technologies LLC acquired a new stake in Revvity during the 2nd quarter valued at $49,000. Hedge funds and other institutional investors own 86.65% of the company's stock.

Revvity Trading Up 1.5%

NYSE:RVTY opened at $124.79 on Wednesday. The stock's 50 day moving average price is $112.37 and its 200 day moving average price is $100.63. Revvity Inc. has a 52 week low of $81.22 and a 52 week high of $124.97. The company has a market capitalization of $13.93 billion, a P/E ratio of 59.42, a P/E/G ratio of 2.24 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80.

Revvity (NYSE:RVTY - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. During the same period in the previous year, the firm posted $1.18 earnings per share. The company's revenue for the quarter was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, research analysts forecast that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity's dividend payout ratio is currently 13.33%.

Analysts Set New Price Targets

RVTY has been the subject of several recent analyst reports. Weiss Ratings raised Revvity from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Thursday, July 30th. Robert W. Baird set a $117.00 price target on Revvity in a research report on Wednesday, May 6th. Zacks Research raised Revvity from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 4th. Wall Street Zen lowered Revvity from a "buy" rating to a "hold" rating in a research report on Sunday, August 16th. Finally, Sanford C. Bernstein started coverage on Revvity in a research note on Friday, June 26th. They set a "market perform" rating and a $115.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $108.36.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source